603 related articles for article (PubMed ID: 14750606)
61. Cellular responses to Staphylococcus aureus alpha-toxin in chronic rhinosinusitis with nasal polyps.
Okano M; Fujiwara T; Kariya S; Higaki T; Haruna T; Matsushita O; Noda Y; Makihara S; Kanai K; Noyama Y; Taniguchi M; Nishizaki K
Allergol Int; 2014 Dec; 63(4):563-73. PubMed ID: 25056228
[TBL] [Abstract][Full Text] [Related]
62. Nasal polyps: pathogenesis and treatment implications.
DeMarcantonio MA; Han JK
Otolaryngol Clin North Am; 2011 Jun; 44(3):685-95, ix. PubMed ID: 21621054
[TBL] [Abstract][Full Text] [Related]
63. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
64. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha.
Hamilos DL; Leung DY; Wood R; Bean DK; Song YL; Schotman E; Hamid Q
Am J Respir Cell Mol Biol; 1996 Oct; 15(4):443-50. PubMed ID: 8879177
[TBL] [Abstract][Full Text] [Related]
65. Identification of bacteria isolated from nasal polyps and their ability to produce superantigens and biofilms in Lebanese patients.
Chakhtoura M; Hadi U; Rameh C; Nassar J; Abdelnoor AM
Ear Nose Throat J; 2011 Apr; 90(4):E6. PubMed ID: 21500161
[TBL] [Abstract][Full Text] [Related]
66. The bacteriology of chronic rhinosinusitis with and without nasal polyps.
Niederfuhr A; Kirsche H; Riechelmann H; Wellinghausen N
Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):131-6. PubMed ID: 19221239
[TBL] [Abstract][Full Text] [Related]
67. Role of fungal antigens in eosinophilia-associated cellular responses in nasal polyps: a comparison with enterotoxin.
Okano M; Fujiwara T; Haruna T; Kariya S; Makihara S; Higaki T; Nishizaki K
Clin Exp Allergy; 2011 Feb; 41(2):171-8. PubMed ID: 21039976
[TBL] [Abstract][Full Text] [Related]
68. Superantigen-related T
Rha MS; Kim SW; Chang DY; Lee JK; Kim J; Park SH; Khalmuratova R; Lim HS; Eun KM; Hong SN; Kim DW; Shin EC
J Allergy Clin Immunol; 2020 May; 145(5):1378-1388.e10. PubMed ID: 31987845
[TBL] [Abstract][Full Text] [Related]
69. The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis.
Chegini Z; Didehdar M; Khoshbayan A; Karami J; Yousefimashouf M; Shariati A
Cell Commun Signal; 2022 Mar; 20(1):29. PubMed ID: 35264183
[TBL] [Abstract][Full Text] [Related]
70. The presence of Staphylococcus aureus is not equivalent to an immune reaction to it's enterotoxins.
Corriveau MN; Zhang N; Bachert C
Allergy; 2009 Jun; 64(6):959-60. PubMed ID: 19416138
[No Abstract] [Full Text] [Related]
71. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
[TBL] [Abstract][Full Text] [Related]
72. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis.
Scavuzzo MC; Fattori B; Ruffoli R; Rocchi V; Carpi A; Berni R; Giambelluca MA; Giannessi F
Biomed Pharmacother; 2005 Jul; 59(6):323-9. PubMed ID: 15935609
[TBL] [Abstract][Full Text] [Related]
73. T cells in chronic rhinosinusitis with nasal polyposis.
Ryan MW; Davis LS
Curr Opin Otolaryngol Head Neck Surg; 2010 Jun; 18(3):200-5. PubMed ID: 20182357
[TBL] [Abstract][Full Text] [Related]
74. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.
Bachert C; Gevaert P; Holtappels G; Johansson SG; van Cauwenberge P
J Allergy Clin Immunol; 2001 Apr; 107(4):607-14. PubMed ID: 11295647
[TBL] [Abstract][Full Text] [Related]
75. The microbiology of chronic rhinosinusitis with and without nasal polyps.
Liu Q; Lu X; Bo M; Qing H; Wang X; Zhang L
Acta Otolaryngol; 2014 Dec; 134(12):1251-8. PubMed ID: 25399884
[TBL] [Abstract][Full Text] [Related]
76. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis.
Hauber HP; Manoukian JJ; Nguyen LH; Sobol SE; Levitt RC; Holroyd KJ; McElvaney NG; Griffin S; Hamid Q
Laryngoscope; 2003 Jun; 113(6):1037-42. PubMed ID: 12782818
[TBL] [Abstract][Full Text] [Related]
77. Update on the molecular biology of nasal polyposis.
Bernstein JM
Otolaryngol Clin North Am; 2005 Dec; 38(6):1243-55. PubMed ID: 16326182
[TBL] [Abstract][Full Text] [Related]
78. Defense against biologic warfare with superantigen toxins.
Kaempfer R; Arad G; Levy R; Hillman D
Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
[TBL] [Abstract][Full Text] [Related]
79. The role of sinus disease in asthma.
Bachert C; Patou J; Van Cauwenberge P
Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):29-36. PubMed ID: 16505609
[TBL] [Abstract][Full Text] [Related]
80. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model.
Ooi EH; Wormald PJ; Carney AS; James CL; Tan LW
Laryngoscope; 2007 Jan; 117(1):51-7. PubMed ID: 17202930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
